전립선비대증에서의 Chlormadinone acetate (Prostalⓡ)의 효과
Effect of Chlormadinone acetate(Prostalⓡ) in Patients with Benign Prostatic Hypertrophy
소속 상세정보
이상은/Lee SE
정재용/김영균/Chung JY/Kim YK
KMID : 0358319850260030243
Abstract
Based on the theory that benign prostatic hypertrophy may be induced by androgenic effect of testosterone derivatives, especially 5-alpha - dihydrotestosterone, on prostatic tissue, Chlormadinone acetate(CMA), potent oral synthetic antiandrogen was investigated in the treatment of benign prostatic hypertrophy.
Twenty-two patients of prostatic hypertrophy were studied over six months period with a special reference to uroflowmetry and following results were obtained : 1) Chlormadinone acetate induced improvement of obstructive urinary symptoms in terms of uroflowmetric measurement. 2) It is very worthwhile to initiate medical treatment before undergoing any surgical intervention or when surgery is contraindicated.
키워드
전립선비대증; 약물요법; 프로스탈; chlormadinone acetate; Prostal; BPH
원문 및 링크아웃 정보
등재저널 정보